Floatz logo

5-FLUOROCYTOSINE

IDH1 Mutated Solid Tumors

Tocagen Inc.Small moleculePhase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the IDH1 Mutated Solid Tumors cohort.

Asset / SponsorPhaseRating
Vocimagene Amiretrorepvec
Tocagen Inc.
Phase 1C
5-FC
Tocagen Inc.
Phase 1D

Same molecule, other indications

5-FLUOROCYTOSINE is also rated in:

glioblastomaDormant
CCC
Indicative ·
54 / 100
View asset →
anaplastic astrocytomaDormant
CCC
Indicative ·
52 / 100
View asset →
anaplastic oligodendrogliomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →